Home Stable Isotopes CS-T-99806

Tetradeca-2,4-dien-oyl Carnitine (N,N,N-tri-13C3-methyl)

Stable Isotopes CAT No. CS-T-99806
Enquire
Product Detail

Tetradeca-2,4-dien-oyl Carnitine (N,N,N-tri-13C3-methyl)

Stable Isotopes
Stock Status: Enquire
Live
For Research & Analytical Purposes. Not for Personal use.
Category Stable Isotopes
API Family --
Storage Refer MSDS for complete information.
Hazard Information Refer MSDS for complete information.

Tetradeca-2,4-dien-oyl Carnitine (N,N,N-tri-13C3-methyl) Product Information

Tetradeca-2,4-dien-oyl Carnitine (N,N,N-tri-13C3-methyl) is listed under Stable Isotopes. It is associated with and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-99806.

Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.

Technical Data

Product Name
Tetradeca-2,4-dien-oyl Carnitine (N,N,N-tri-13C3-methyl)
CAS No.
-
CAT No.
CS-T-99806
Molecular Formula
C18ยนยณC3H37NO4
Molecular Weight
370.5
Category
Storage Condition
Refer MSDS for complete information.
IUPAC Name
"Tetradeca-2,4-dien-oyl Carnitine (N,N,N-tri-13C3-methyl)"
Hazard Compound
Refer MSDS for complete information.

Description

Overview
"Tetradeca-2,4-dien-oyl Carnitine (N,N,N-tri-13C-methyl) is labeled isotope form Tetradeca-2,4-dien-oyl Carnitine (T292010) that is derived from Methyl 4-Bromocrotonate (M294110), which is a useful synthetic intermediate. It was used in the synthesis of irreversible inhibitors of EGFR and HER-2 tyrosine kinases with enhanced anti-tumor activities."
Synonyms
Tetradeca-2,4-dien-oyl Carnitine (N,N,N-tri-13C3-methyl)
Application Notes
"Tetradeca-2,4-dien-oyl Carnitine (N,N,N-tri-13C-methyl) is labeled isotope form Tetradeca-2,4-dien-oyl Carnitine (T292010) that is derived from Methyl 4-Bromocrotonate (M294110), which is a useful synthetic intermediate. It was used in the synthesis of irreversible inhibitors of EGFR and HER-2 tyrosine kinases with enhanced anti-tumor activities."
References
"Tsou, H., et al.: J. Med. Chem., 44, 2719 (2001); Pisaneschi, F., et al.: Bioorg. Med. Chem., 18, 6634 (2010)"
Downloading MSDSโ€ฆ
Done
Done
RFQ Basket 0
Done
RFQ Basket 0
Quick Enquiry
Tell us what you need
Quote Basket
Selected RFQ Items
Your RFQ basket is empty. Add a product block or copy a guided requirement here.